HMPQ is our new & exciting sub-penny CBD alert for tomorrow.
=====================
HempAmericana, Inc (HMPQ)
Alert Price: $0.0007
Website | Recent News
========================
Members,
We are coming off and incredible week of trading.
Last Thursday's alert broke out huge on on Friday, giving our members ample time to secure up to +76% in realistic profit.
This was our 4th winning trade alert in a row.
All in all, our members have had the opportunity to secure up to +225% in realistic profit in just about two weeks time.
We plan on keeping the good times rolling with a fresh trade idea that has the potential to double in price.
Please turn your immediate attention to HempAmericana, Inc (HMPQ).
Just like our most recent winners, HMPQ is sitting on a bottom'd out chart with plenty of room to the upside.
We've had a lot of success in the cannabis sector, our last pick in this space more than doubled in price in a very short amount of time.
HMPQ is quite enticing at the moment, as there are not many companies in the CBD sector trading for less than a penny.
And if there are, it is unlikely that they own and operate a high-capacity, state-of-the-art CBD extraction and processing facility like HMPQ does.
This is an exciting time for HMPQ shareholders, as the Company is witnessing quite the growth period.
Management recently updated shareholders on current inventory levels on hand for premium-quality CBD products. As of July 15, 2019, the Company holds CBD-based product inventories in excess of $500,000 based on current market pricing for end-market sales of comparable products. This inventory represents production over the past 60 days and includes CBD Extract, Crude CBD Oil , CBD Distillate, and bottled CBD Tincture.
Management believes it will improve margins over time as production smooths out and the volume absorbs fixed operating cost.
This is the kind of news we like to hear.
Wall St . loves nothing more than healthy margins and revenue growth.
It appears that we have found another gem in the CBD space with HMPQ.
We are urging all of our members to start their research on HMPQ immediately, and consider building a position tomorrow morning at 9:30AM EST.
About HempAmericana, Inc.
HempAmericana is an emerging participant in the CBD products market. The Company owns and operates a high-capacity, state-of-the-art CBD extraction and processing facility located in Augusta, Maine. This facility is armed with a supersized supercritical CO2 extraction system, centrifugal partition chromatography refinement technology, and a mechanized fully-automated CBD bottling system. The Company’s CBD oil business uses the brand designation, “Weed Got Oil”. HempAmericana also researches, develops, and sells products made of industrial hemp, including a popular brand of hemp rolling papers marketed under the brand name, “Rolling Thunders”. See more at www.hempamericana.com.
This Is An Exciting Time To Be A HMPQ Shareholder
In a recent corporate update CEO Salvador Rosillo painted a picture of a company gearing up for an amazing 2nd half of 2018.
Highlights Include:
A new relationship with Eagle Hemp of Florida (“Eagle Hemp”), located in the West Palm Beach area. This relationship now comprises an initial large purchase order and a clear path for a continuing series of purchase orders set to roll out over coming months and quarters.
Vaping machine is active and fully operational, they are now ready to produce and sell CBD vapes.
Plans to build a greenhouse dedicated to cultivating super-enriched seeds.
Improved margins
Please feel free to read the entire letter to shareholders below, we think you'll be just as impressed as we are.
Dear Valued Shareholder,
As we begin to establish growing momentum in our core CBD Oil production and distribution business, I wanted to take this opportunity to express our gratitude for your commitment and loyalty to our long-term value proposition and to discuss our current opportunities and our roadmap as we gear up to execute on the powerful opportunities that lie ahead.
As you know, we have commenced bottling 500mg and 1000mg full-spectrum CBD distillate in our state-of-the-art CBD extraction and production facility in Augusta, Maine. Our inaugural production expectations are set at production of 2,000 bottles per day with a gradual increase to 8,000 bottles per day to fill demand. We already have over 50,000 bottles of full-spectrum distillate bottled and ready to ship with tens of thousands to follow.
We are also bottling a 250mg potency, which is perfect for the CBD-for-pets market. And, on the high end, we are also bottling 2500mg and 5000mg strengths, but we can replicate any formula.
Much of this production will be distributed under our proprietary brand, “Weed Got Oil”. But we are also actively pursuing a major place in the white label market for premium full-spectrum distillate CBD oil . There are over 400 brands now in the CBD space, and most of them turn to a major high-capacity producer, like HempAmericana, to build up an inventory of product.
For example, we recently announced a new relationship with Eagle Hemp of Florida (“Eagle Hemp”), located in the West Palm Beach area. This relationship now comprises an initial large purchase order and a clear path for a continuing series of purchase orders set to roll out over coming months and quarters.
The terms of the deal provide a window into the framework we have been working toward as we leverage our capital investments in our Augusta facility for the white label opportunity. We are set to receive strong demand at strong terms, including compensation for high-volume production of our premium CBD Oil output as well as our bottling technology.
In all, just in the first of these planned orders, we will receive a substantial revenue input, with no costs associated with bottling, labeling, or shipping of the final product.
Eagle Hemp is just one of many customers currently in play for our premium product output. The CBD market is turning out to be every bit the juggernaut that the major analyst firms have been suggesting over the past year. Estimates now range from several hundred to several thousand percentage points of gross sales expansion in the space over the next 36-48 months, which is a reasonable definition of boom conditions for a major industry in robust infancy.
The driver here, as we have elaborated in past communications, is about the seemingly bottomless demand growth function that accompanies the evolution of a product category from fringe consumer niche to mainstream adoption.
It is also important to note that we continue to receive requests from other industry customers and we are in the process of investigating the credibility of such requests and in negotiating similar terms for concrete relationships.
In addition, our production facility and lab are running along in amazing fashion. We now have two bottling machines active and operational due to the tremendous interest coming in the door. Once we have distilled this interest into official purchase orders, we will divulge them in our communications.
We also want to announce that our vaping machine is active and fully operational, we are now ready to produce and sell CBD vapes.
Finally, as we continue to expand, diversify, and integrate, we are now also working on plans to build a greenhouse dedicated to cultivating super-enriched seeds. We have always been committed to the long-term goal of fully controlling our production ecosystem from seed to product, and this is the next step in establishing that fully vertical model, where we see the strongest margins.
Best Regards,
Salvador Rosillo
As you can see, this is a company built for growth, and at just $0.007 per share, this could be one of the biggest steals in the entire cannabis sector.
Market Outlook for CBD:
New projections from the Brightfield Group in its June report suggest, if anything, a further acceleration in the overall growth of the CBD space, and some suggestion that this acceleration is being driven by an increasingly tangible jump in mainstream consumer adoption of CBD-based products. Specifically, the report notes that 2019 will show a 700% jump relative to 2018 levels for all domestic sales of CBD-based products, with 2019 on pace to exceed $5 billion in total sales of products containing CBD given current data. In addition, according to the Brightfield Group researchers, much of this jump will be due to sales in mainstream retail chain stores.
The cannabis market has grown at a tremendous pace over the recent years and as such, the industry has established itself a major global market. According to data compiled by Grand View Research, the global legal cannabis market is projected to reach USD 146.4 Billion by the 2025. It is also expected to grow at a CAGR of 34.6%. The market itself is witnessing a widespread legalization movement due to the growing adoption of the plant within the medical sector. Cannabis is being used heavily around the global for medical applications and treatments for maladies such as cancer, mental disorders, chronic pain, and others. However, the recreational market is thriving as well due specifically to the U.S. and Canada. States like California, Colorado, and Nevada are expected to propel the recreational sector forward at an encouraging rate.
The acceleration of research and development has led to new products within the market, enhancing consumer experiences. The research suggests that the industry is expecting strong exchanges of technological knowledge and information. Meanwhile, as countries like Canada, the U.S., Germany, and Australia lead the market in sales, countries like Israel are focusing on research and technology development to further expand within the industry. Additionally, there are various new forms of technology being introduced into the cannabis sector, such as virtual reality, payment solutions, and medical devices. "That's why we firmly believe that technology stands at the center of the industry's advancement and growth," said Ben Curren Chief Executive Officer of Green Bits, "This innovation will continue to generate market growth, improve public perception, protect public health and safety and enhance the implementation of state programs and regulations.
CBD is becoming widely accepted by consumers and countries. For example, in the U.S., CBD became legal after the Farm Bill that passed in late 2018.
That in mind, consumers could easily find CBD products across the U.S. In turn, we may actually see some CBD companies generating more revenues and earnings than cannabis companies.
Now, investment bank Cowen & Co. analysts estimate that the CBD market will reach $16B by 2025.
That said, CBD companies could experience exponential growth rates with such a large market. Not only that, large-cap drug stores like CVS and Walgreens have bet on CBD .
Additionally, CVS and Walgreens noted they would offer CBD products in more than 2,000 stores across the U.S.
Technical Analysis
Subpenny Stocks = Big Moves
We love these subpenny alerts because even the smallest move can result in massive gains for traders.
As we mentioned above, HMPQ is sitting on a bottom'd out chart with plenty of room to the upside.
We love these type of alerts because the downside risk appears minimal, but the upside is almost too good to ignore.
HMPQ is trading well off its 52-week of $0.0277.
A run back to those levels would net traders nearly +300% in profit from today's alert price.
We've done our very own chart analysis and see the potential for an explosive move in the very near future.
The Bottom-Line
We've been right on the money with our most recent cannabis sector alerts.
HMPQ is exactly the type of alert that we look for. Undervalued with major growth potential.
These are the types of alerts that offer traders the biggest payoff potential.
This could be our next subpenny alert to double in price, so make sure you have it on your radar!
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated seventeen thousand five hundred dollars by One 22 Media LLC to conduct a one-day investor relations advertising and marketing campaign and 1,500 Trading View™ views for HMPQ. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
HempAmericana, Inc (HMPQ)
Alert Price: $0.0007
Website | Recent News
========================
Members,
We are coming off and incredible week of trading.
Last Thursday's alert broke out huge on on Friday, giving our members ample time to secure up to +76% in realistic profit.
This was our 4th winning trade alert in a row.
All in all, our members have had the opportunity to secure up to +225% in realistic profit in just about two weeks time.
We plan on keeping the good times rolling with a fresh trade idea that has the potential to double in price.
Please turn your immediate attention to HempAmericana, Inc (HMPQ).
Just like our most recent winners, HMPQ is sitting on a bottom'd out chart with plenty of room to the upside.
We've had a lot of success in the cannabis sector, our last pick in this space more than doubled in price in a very short amount of time.
HMPQ is quite enticing at the moment, as there are not many companies in the CBD sector trading for less than a penny.
And if there are, it is unlikely that they own and operate a high-capacity, state-of-the-art CBD extraction and processing facility like HMPQ does.
This is an exciting time for HMPQ shareholders, as the Company is witnessing quite the growth period.
Management recently updated shareholders on current inventory levels on hand for premium-quality CBD products. As of July 15, 2019, the Company holds CBD-based product inventories in excess of $500,000 based on current market pricing for end-market sales of comparable products. This inventory represents production over the past 60 days and includes CBD Extract, Crude CBD Oil , CBD Distillate, and bottled CBD Tincture.
Management believes it will improve margins over time as production smooths out and the volume absorbs fixed operating cost.
This is the kind of news we like to hear.
Wall St . loves nothing more than healthy margins and revenue growth.
It appears that we have found another gem in the CBD space with HMPQ.
We are urging all of our members to start their research on HMPQ immediately, and consider building a position tomorrow morning at 9:30AM EST.
About HempAmericana, Inc.
HempAmericana is an emerging participant in the CBD products market. The Company owns and operates a high-capacity, state-of-the-art CBD extraction and processing facility located in Augusta, Maine. This facility is armed with a supersized supercritical CO2 extraction system, centrifugal partition chromatography refinement technology, and a mechanized fully-automated CBD bottling system. The Company’s CBD oil business uses the brand designation, “Weed Got Oil”. HempAmericana also researches, develops, and sells products made of industrial hemp, including a popular brand of hemp rolling papers marketed under the brand name, “Rolling Thunders”. See more at www.hempamericana.com.
This Is An Exciting Time To Be A HMPQ Shareholder
In a recent corporate update CEO Salvador Rosillo painted a picture of a company gearing up for an amazing 2nd half of 2018.
Highlights Include:
A new relationship with Eagle Hemp of Florida (“Eagle Hemp”), located in the West Palm Beach area. This relationship now comprises an initial large purchase order and a clear path for a continuing series of purchase orders set to roll out over coming months and quarters.
Vaping machine is active and fully operational, they are now ready to produce and sell CBD vapes.
Plans to build a greenhouse dedicated to cultivating super-enriched seeds.
Improved margins
Please feel free to read the entire letter to shareholders below, we think you'll be just as impressed as we are.
Dear Valued Shareholder,
As we begin to establish growing momentum in our core CBD Oil production and distribution business, I wanted to take this opportunity to express our gratitude for your commitment and loyalty to our long-term value proposition and to discuss our current opportunities and our roadmap as we gear up to execute on the powerful opportunities that lie ahead.
As you know, we have commenced bottling 500mg and 1000mg full-spectrum CBD distillate in our state-of-the-art CBD extraction and production facility in Augusta, Maine. Our inaugural production expectations are set at production of 2,000 bottles per day with a gradual increase to 8,000 bottles per day to fill demand. We already have over 50,000 bottles of full-spectrum distillate bottled and ready to ship with tens of thousands to follow.
We are also bottling a 250mg potency, which is perfect for the CBD-for-pets market. And, on the high end, we are also bottling 2500mg and 5000mg strengths, but we can replicate any formula.
Much of this production will be distributed under our proprietary brand, “Weed Got Oil”. But we are also actively pursuing a major place in the white label market for premium full-spectrum distillate CBD oil . There are over 400 brands now in the CBD space, and most of them turn to a major high-capacity producer, like HempAmericana, to build up an inventory of product.
For example, we recently announced a new relationship with Eagle Hemp of Florida (“Eagle Hemp”), located in the West Palm Beach area. This relationship now comprises an initial large purchase order and a clear path for a continuing series of purchase orders set to roll out over coming months and quarters.
The terms of the deal provide a window into the framework we have been working toward as we leverage our capital investments in our Augusta facility for the white label opportunity. We are set to receive strong demand at strong terms, including compensation for high-volume production of our premium CBD Oil output as well as our bottling technology.
In all, just in the first of these planned orders, we will receive a substantial revenue input, with no costs associated with bottling, labeling, or shipping of the final product.
Eagle Hemp is just one of many customers currently in play for our premium product output. The CBD market is turning out to be every bit the juggernaut that the major analyst firms have been suggesting over the past year. Estimates now range from several hundred to several thousand percentage points of gross sales expansion in the space over the next 36-48 months, which is a reasonable definition of boom conditions for a major industry in robust infancy.
The driver here, as we have elaborated in past communications, is about the seemingly bottomless demand growth function that accompanies the evolution of a product category from fringe consumer niche to mainstream adoption.
It is also important to note that we continue to receive requests from other industry customers and we are in the process of investigating the credibility of such requests and in negotiating similar terms for concrete relationships.
In addition, our production facility and lab are running along in amazing fashion. We now have two bottling machines active and operational due to the tremendous interest coming in the door. Once we have distilled this interest into official purchase orders, we will divulge them in our communications.
We also want to announce that our vaping machine is active and fully operational, we are now ready to produce and sell CBD vapes.
Finally, as we continue to expand, diversify, and integrate, we are now also working on plans to build a greenhouse dedicated to cultivating super-enriched seeds. We have always been committed to the long-term goal of fully controlling our production ecosystem from seed to product, and this is the next step in establishing that fully vertical model, where we see the strongest margins.
Best Regards,
Salvador Rosillo
As you can see, this is a company built for growth, and at just $0.007 per share, this could be one of the biggest steals in the entire cannabis sector.
Market Outlook for CBD:
New projections from the Brightfield Group in its June report suggest, if anything, a further acceleration in the overall growth of the CBD space, and some suggestion that this acceleration is being driven by an increasingly tangible jump in mainstream consumer adoption of CBD-based products. Specifically, the report notes that 2019 will show a 700% jump relative to 2018 levels for all domestic sales of CBD-based products, with 2019 on pace to exceed $5 billion in total sales of products containing CBD given current data. In addition, according to the Brightfield Group researchers, much of this jump will be due to sales in mainstream retail chain stores.
The cannabis market has grown at a tremendous pace over the recent years and as such, the industry has established itself a major global market. According to data compiled by Grand View Research, the global legal cannabis market is projected to reach USD 146.4 Billion by the 2025. It is also expected to grow at a CAGR of 34.6%. The market itself is witnessing a widespread legalization movement due to the growing adoption of the plant within the medical sector. Cannabis is being used heavily around the global for medical applications and treatments for maladies such as cancer, mental disorders, chronic pain, and others. However, the recreational market is thriving as well due specifically to the U.S. and Canada. States like California, Colorado, and Nevada are expected to propel the recreational sector forward at an encouraging rate.
The acceleration of research and development has led to new products within the market, enhancing consumer experiences. The research suggests that the industry is expecting strong exchanges of technological knowledge and information. Meanwhile, as countries like Canada, the U.S., Germany, and Australia lead the market in sales, countries like Israel are focusing on research and technology development to further expand within the industry. Additionally, there are various new forms of technology being introduced into the cannabis sector, such as virtual reality, payment solutions, and medical devices. "That's why we firmly believe that technology stands at the center of the industry's advancement and growth," said Ben Curren Chief Executive Officer of Green Bits, "This innovation will continue to generate market growth, improve public perception, protect public health and safety and enhance the implementation of state programs and regulations.
CBD is becoming widely accepted by consumers and countries. For example, in the U.S., CBD became legal after the Farm Bill that passed in late 2018.
That in mind, consumers could easily find CBD products across the U.S. In turn, we may actually see some CBD companies generating more revenues and earnings than cannabis companies.
Now, investment bank Cowen & Co. analysts estimate that the CBD market will reach $16B by 2025.
That said, CBD companies could experience exponential growth rates with such a large market. Not only that, large-cap drug stores like CVS and Walgreens have bet on CBD .
Additionally, CVS and Walgreens noted they would offer CBD products in more than 2,000 stores across the U.S.
Technical Analysis
Subpenny Stocks = Big Moves
We love these subpenny alerts because even the smallest move can result in massive gains for traders.
As we mentioned above, HMPQ is sitting on a bottom'd out chart with plenty of room to the upside.
We love these type of alerts because the downside risk appears minimal, but the upside is almost too good to ignore.
HMPQ is trading well off its 52-week of $0.0277.
A run back to those levels would net traders nearly +300% in profit from today's alert price.
We've done our very own chart analysis and see the potential for an explosive move in the very near future.
The Bottom-Line
We've been right on the money with our most recent cannabis sector alerts.
HMPQ is exactly the type of alert that we look for. Undervalued with major growth potential.
These are the types of alerts that offer traders the biggest payoff potential.
This could be our next subpenny alert to double in price, so make sure you have it on your radar!
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated seventeen thousand five hundred dollars by One 22 Media LLC to conduct a one-day investor relations advertising and marketing campaign and 1,500 Trading View™ views for HMPQ. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
=====================
HempAmericana, Inc (HMPQ)
Alert Price: $0.007
========================